Jazz Pharmaceuticals plc (JAZZ) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures…
Source: Yahoo Finance
Sector & Industry
Jazz Pharmaceuticals plc operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Jazz Pharmaceuticals plc at a Glance
| Company | Jazz Pharmaceuticals plc |
| Ticker | JAZZ |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $246.81 |
| Market cap | $16.02B |
| P/E ratio (trailing) | 16.89 |
| EPS (trailing) | $14.61 |
| 52-week high | $266.38 |
| 52-week low | $123.88 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.36 |
| Return on equity (ROE) | 22.11% |
| Debt-to-equity | 91.83% |
| Average volume | 902,550 |
| Shares outstanding | 64.91M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2,890 |
| Country | Ireland |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Jazz Pharmaceuticals plc's current P/E ratio?
- Jazz Pharmaceuticals plc (JAZZ) has a trailing P/E ratio of 16.89 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Jazz Pharmaceuticals plc's market capitalisation?
- Jazz Pharmaceuticals plc's market cap is $16.02B based on our latest snapshot. See how it ranks by market cap →
- What is JAZZ's 52-week range?
- Over the past 52 weeks, JAZZ has traded between $123.88 and $266.38. What does the 52-week range mean? →
- How volatile is Jazz Pharmaceuticals plc compared to the market?
- Jazz Pharmaceuticals plc has a beta of 0.36, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Jazz Pharmaceuticals plc pay a dividend?
- Jazz Pharmaceuticals plc does not currently pay a dividend according to our latest data.
- What exchange is JAZZ listed on?
- JAZZ is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Jazz Pharmaceuticals plc in?
- Jazz Pharmaceuticals plc is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →